Fundraising Fox

Hans J. Moebius

Investor

Venture Advisor at Andera Partners

Baar, Zug, Switzerland

About

Hans J. Moebius is a Venture Advisor at Andera Partners, focusing on central nervous system drug development. He holds a B.S. in Chemistry, a medical degree, and a PhD in Experimental Pharmacology, and is a board-certified neurologist (FAAN) and psychiatrist with a European Certificate in Pharmaceutical Medicine. His career spans over a decade of clinical work in university settings and more than 30 years in the pharmaceutical industry, including a role as Chief Medical Officer during Athira's 2020 IPO and involvement in the development of therapies for conditions such as Alzheimer's disease, hepatic encephalopathy, Lennox-Gastaut syndrome, and ADHD.

Experience

  1. Andera PartnersVenture Advisorcurrent2024 — present
  2. EXCIVA GmbHCo-Founder and Chief Medical Officercurrent2024 — presentHeidelberg, Baden-Württemberg, Germany
  3. EXCIVA GmbHScientific Advisory Board member2019 — 2024Heidelberg, Baden-Württemberg, Germany
  4. EXCIVA GmbHCo-Founder, CEO and CMO2016 — 2019Heidelberg, Baden-Württemberg, Germany
  5. Athira PharmaSenior Scientific Advisorcurrent2024 — presentBothell, Washington, United States
  6. Athira PharmaCMO2019 — 2024Bothell, Washington, United States
  7. Rodin TherapeuticsChief Medical Officer2016 — 2017Cambridge, Massachusetts, United States
  8. FORUM Pharmaceuticals Inc.VP Clinical Research Europe2012 — 2016Zürich Area, Switzerland
  9. CHASE PharmaceuticalsExec. VP R&D2016Washington DC
  10. TauRx Therapeutics Ltd.Chief Medical Officer2009 — 2012Singapore
  11. INC ResearchSenior Vice President2007 — 2009Raleigh, NC and Zurich, Switzerland
  12. Merz PharmaceuticalsCSO1996 — 2006Frankfurt/M, Germany
  13. NovartisHead Global Medical Affairs, CNS1995 — 1996Basel
  14. CibaClinical R&D CNS1991 — 1995Basel, Switzerland

Skills & more

Clinical Development35Neurology27Pharmaceutical Industry24Clinical Research20Medical Affairs9Psychiatry8CRO7Clinical Trials16Regulatory Affairs4Pharmacology3Neuroscience4Drug Development16
+7 moreTranslational MedicineAlzheimer's diseaseR&DLifesciencesBiotechnologyMedicineLife Sciences

Languages English · French · German · Italian

From Hans's professional profile.

Colleagues at Andera Partners

Aneta Sottil
Partner at Andera Partners
Anne-Laure Delavergne
Middle Office at Andera Partners
Antoine Guérillon
Investment Director at Andera Partners
Antoine Le Bourgeois
Partner at Andera Partners
Armelle Okoye
Middle Office at Andera Partners
Arthur Milliard
Investor at Andera Partners
Augustin Bayvet
Senior Investment Manager at Andera Partners
Bruno Angles
Strategic Advisor at Andera Partners

Frequently asked questions

Who is Hans J. Moebius?
Hans J. Moebius is a Venture Advisor at Andera Partners, focusing on central nervous system drug development. He holds a B.S. in Chemistry, a medical degree, and a PhD in Experimental Pharmacology, and is a board-certified neurologist (FAAN) and psychiatrist with a European Certificate in Pharmaceutical Medicine. His career spans over a decade of clinical work in university settings and more than 30 years in the pharmaceutical industry, including a role as Chief Medical Officer during Athira's 2020 IPO and involvement in the development of therapies for conditions such as Alzheimer's disease, hepatic encephalopathy, Lennox-Gastaut syndrome, and ADHD.
Where does Hans J. Moebius work?
Hans J. Moebius is Venture Advisor at Andera Partners.
Where did Hans J. Moebius go to school?
Hans J. Moebius studied at Goethe University Frankfurt (Board Certifications Neurology, Psychiatry); Max-Planck-Institute for Brain Research, Frankfurt/M (Neurodegenerative diseases, neuro-oncology); Heidelberg University (MD, PhD).

Same school

Also attended Goethe University Frankfurt42

Marcel HollerbachInvestor at Cavalry VenturesDaniel von DevivereVenture Scout at Storm VenturesJohannes FruehaufGeneral Partner at Mission BiocapitalLeonard LangAssociate at BlockwallOliver ManojlovicVP Sales at Personio at PICUS CAPITALSaid HaschemiInvestor at HV Capital

+ 36 more

Also attended Heidelberg University44

Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Keita Yazakiシニア・アソシエイト (Senior Associate) at CyberAgent CapitalLena ThiedeCo-Founder & General Partner at Planet A VenturesFabian HeilemannFounder & CEO at AENUJan MarchewskiPrincipal at Hitachi VenturesStella PaffenholzSenior Associate at Atlas Venture

+ 38 more

Also attended Université de Bordeaux15

Jeff PomeranzManaging Director at RSCMMarc WeillVC Analyst Intern at OneRagtimeBrice LapoublePartner at Axeleo CapitalOlivier DubuissonManaging Partner at KaristaMarie AsanoPartner at European Circular Bioeconomy FundDavid WongResearch Advisor at Archetype

+ 9 more

Shared employers

Also worked at Athira Pharma3

Leen KawasManaging General Partner at Propel Bio PartnersCarol CrinerAdvisor at Propel Bio PartnersGrant PickeringFounder at Vaxcyte

Also worked at INC Research1

John PotthoffDigital Pharma Advisor at Excelerate Health Ventures

Also worked at Merz Pharmaceuticals1

Karen LaRochelleVenture Partner at Advent Life Sciences

Also worked at Novartis130

Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures

+ 124 more